Supplements traditional pharmaceutical and psychotherapeutic care with a holistic and personalized treatment course.
Learn More
Treatments designed to help you manage substance use concerns to break the cycle of substance use.
What We Treat
Drug Use Disorder
Alcohol Use Disorder
Smoking Addiction
Treatment Options
Transcranial
Magnetic Stimulation
Magnetic Stimulation
IV Ketamine Therapy
Integrative Psychotherapy
Dual Sympathetic Block
Transcranial Magnetic Stimulation (TMS)
Research suggests a strong correlation between addiction and both overactivity and under activity in specific regions of the brain that regulate cravings, motivation for use, and reenforcing rewards rewards. 1
TMS can help to regulate activity in specific areas of the brain to manage cravings and reduce addiction-related symptoms, including depression.
TMS for Smoking Cessation Protocol
18 TMS treatment sessions in 6 weeks.
18 TMS treatment sessions in 6 weeks.
- Every treatment session consists of a brief provocation designed to activate neurocircuitry associated with addiction.
- Following the provocation, you will sit under the TMS helmet for 18 minutes.
- Your session will end with brief counseling.
IV Ketamine Therapy
Ketamine is beneficial for treatment of depression and anxiety, but it can also be an effective treatment for addressing the foundations of substance use. Its ability to enhance neuroplasticity and neurogenesis can be leveraged to forge new learning and behaviors. 2
We follow the ketamine for the reduction of alcohol relapse (KARE) model, which was developed by researchers from Exeter University.3 This outpatient program combines psychotherapy with ketamine treatments to better understand individual addictive patterns and behaviors.
abstinence rate over 6 months*
*Studies have shown that this model elicits an 86% alcohol
abstinence rate over a six-month period.4
abstinence rate over a six-month period.4
Integrative Psychotherapy
Anxiety, depression, and trauma are strongly associated with substance use disorder.
We work with you to develop treatment plans based on your medical history and lifestyle goals. Drawing from a range of therapeutic approaches, including cognitive behavioral therapy (CBT) and harm reduction, our specialists will help you reframe your relationship to substances and integrate sustainable behavioral changes.
Dual Sympathetic Block
The Dual Sympathetic Block is a minimally invasive injection that resets the sympathetic nervous system’s fight-or-flight response back to its pre-trauma state.
Many studies and case reports highlight high comorbidity rates between PTSD and substance use disorders. 5 It is estimated that between 36% and 50% of people who meet the criteria for substance use disorder also meet the criteria for lifetime PTSD.6 Additionally, there is a strong correlation between people with PTSD and drug abuse.
Benefits of Interventional Care
- Lower Cost Care
- Personalized Care
In-patient rehab programs can cost up to $50,000. Our interventional approach to substance use disorder activates a fast and long-lasting response that is significantly more cost-effective.
Your health needs are unique to you, and your treatment program should be, too. Our medical team works with you to build a treatment plan that fits into your lifestyle and supports your long-term health goals.
Integrated treatments not only diminish symptoms, but may improve overall mental and physical health, and quality of life.
Meet Your Doctor
Dr. Marcel Green, MD
Dr. Marcel Green is a double board-certified psychiatrist and Columbia University medical school graduate. He specializes in integrating breakthrough interventional psychiatric treatments with traditional psychiatric and psychological treatment models.
- Zhang JJQ, Fong KNK, Ouyang RG, Siu AMH, Kranz GS. Effects of repetitive transcranial magnetic stimulation (rTMS) on craving and substance consumption in patients with substance dependence: a systematic review and meta-analysis. Addiction. 2019;114(12):2137-2149. https://pubmed.ncbi.nlm.nih.gov/31328353/
- Ivan Ezquerra-Romano I, Lawn W, Krupitsky E, Morgan CJA. Ketamine for the treatment of addiction: Evidence and potential mechanisms. Neuropharmacology. 2018 Nov;142:72-82. doi: 10.1016/j.neuropharm.2018.01.017. Epub 2018 Jan 12. PMID: 29339294.
- Grabski, Meryem, et al. “Adjunctive ketamine with relapse prevention–based psychological therapy in the treatment of alcohol use disorder.” American Journal of Psychiatry, vol. 179, no. 2, 2022, pp. 152–162, https://doi.org/10.1176/appi.ajp.2021.21030277.
- https://awaknlifesciences.com/awakn-announces-positive-results-from-phase-ii-a-b-clinical-trial
- Michaels TI, Stone E, Singal S, Novakovic V, Barkin RL, Barkin S. Brain reward circuitry: The overlapping neurobiology of trauma and substance use disorders. World J Psychiatry. 2021 Jun 19;11(6):222-231. doi: 10.5498/wjp.v11.i6.222. PMID: 34168969; PMCID: PMC8209534.
- Brady KT, Back SE, Coffey SF. Substance abuse and posttraumatic stress disorder. Curr Dir in Psych Sci. 2004;13:206–209.
